Alsius Corporation Reports Record Fourth Quarter and Full Year 2007 Financi...( - Conference Call/Webcast at ...),Health

- Conference Call/Webcast at 4:30 p.m. Eastern Time Today -

IRVINE, Calif., March 13 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular patient temperature management therapies, today reported on its corporate progress and financial results for the fourth quarter and year ended December 31, 2007.

Revenue for the fourth quarter of 2007 was a record $2.7 million, compared to $2.0 million in the fourth quarter of 2006. Revenue for the full year 2007 was also a record of $9.1 million, compared to $6.0 million in 2006. These results were due to growth in sales of intravascular temperature management systems, as well as increased sales of catheters due to the growing installed base.

"We are proud to report our strongest quarter and year in Alsius history, which is a direct result of our continued investment in developing the leading intravascular temperature management solutions," said Bill Worthen, President and CEO of Alsius. "Our customers are becoming increasingly aware of the importance of precise temperature management in critically ill patients and recognize the value of our technology as the right solution. Our efforts in 2008 will be focused on continuing to develop the market for our products -- increasing awareness of the importance of temperature management and the benefits of our technology versus conventional approaches."

Additional Fourth Quarter and Full Year 2007 Financial Results

In the fourth quarter of 2007, gross profit was $0.8 million, compared to $0.3 million in the fourth quarter of 2006. For the full year 2007, gross profit was $1.8 million, compared to a loss of $0.2 million for the same period the prior year.

Total operating
'/>"/>